{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T10:52:42Z","timestamp":1781952762219,"version":"3.54.5"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Pharmacokinet Pharmacodyn"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s10928-026-10030-1","type":"journal-article","created":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T10:36:57Z","timestamp":1775039817000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Development of a population pharmacokinetics model and an R-Shiny simulation platform for moxifloxacin pharmacokinetics in non-human primates"],"prefix":"10.1007","volume":"53","author":[{"given":"Arnay","family":"Garhyan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek","family":"Leishman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,1]]},"reference":[{"issue":"7","key":"10030_CR1","first-page":"473","volume":"42","author":"M Li","year":"2017","unstructured":"Li M, Ramos LG (2017) Drug-Induced QT Prolongation And Torsades de Pointes. Pharm Ther 42(7):473\u2013477","journal-title":"Pharm Ther"},{"issue":"11","key":"10030_CR2","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1136\/heart.89.11.1363","volume":"89","author":"YG Yap","year":"2003","unstructured":"Yap YG, Camm AJ (2003) Drug induced QT prolongation and torsades de pointes. Heart 89(11):1363\u20131372","journal-title":"Heart"},{"key":"10030_CR3","unstructured":"International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use. E14\/S7B Questions and Answers: Clinical and Nonclinical Evaluation of QT\/QTc Interval Prolongation and Proarrhythmic Potential Training Materials (2022) March https:\/\/database.ich.org\/sites\/default\/files\/ICH_E14-S7B_TrainingMaterial_2022_0407.pdf. Accessed on 24 June 2025"},{"key":"10030_CR4","unstructured":"European Medicine Agency. ICH guideline E14\/S7B: clinical and nonclinical evaluation of QT\/QTc interval prolongation and proarrhythmic potential - questions and answers - Scientific guideline (2022) March https:\/\/www.ema.europa.eu\/en\/ich-guideline-e14-s7b-clinical-nonclinical-evaluation-qt-qtc-interval-prolongation-proarrhythmic-potential-questions-answers-scientific-guideline. Accessed on 24 June 2025"},{"issue":"1","key":"10030_CR5","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1186\/1757-1626-1-409","volume":"1","author":"T Koide","year":"2008","unstructured":"Koide T, Shiba M, Tanaka K, Muramatsu M, Ishida S, Kondo Y, Watanabe K (2008) Severe QT interval prolongation associated with moxifloxacin: a case report. Cases J 1(1):409","journal-title":"Cases J"},{"key":"10030_CR6","unstructured":"Delpy E, Metat AM, Coquelin KS, Infanti F, Drieu La Rochelle C (2013) Assessment of drug-induced cardiovascular effects by telemetry in group-housed cynomolgus monkeys. 13th Annual Meeting of Safety Pharmacology Society, Rotterdam. https:\/\/nc3rs.org.uk\/sites\/default\/files\/2022-01\/Assessment%20of%20drug-induced%20cardiovascular%20effects%20by%20telemetry%20in%20group-housed%20cynomolgus%20monkeys.%20Poster%20SPS%202013.pdf. Accessed on 24 June 2025"},{"key":"10030_CR7","doi-asserted-by":"publisher","first-page":"1055031","DOI":"10.3389\/fphar.2023.1055031","volume":"14","author":"H Izumi-Nakaseko","year":"2023","unstructured":"Izumi-Nakaseko H, Sakamoto K, Goto A, Kambayashi R, Matsumoto A, Takei Y, Takahara A, Sugiyama A (2023) Characterization of pathological remodeling in the chronic atrioventricular block cynomolgus monkey heart. Front Pharmacol 14:1055031","journal-title":"Front Pharmacol"},{"issue":"3","key":"10030_CR8","doi-asserted-by":"publisher","first-page":"e00021","DOI":"10.1002\/psp4.21","volume":"4","author":"J Wojciechowski","year":"2015","unstructured":"Wojciechowski J, Hopkins AM, Upton RN (2015) Interactive Pharmacometric Applications Using R and the Shiny Package. CPT Pharmacometrics Syst Pharmacol 4(3):e00021","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"key":"10030_CR9","unstructured":"National Center for the Replacement (2026) Refinement & Reduction of Animals in Research (NC3Rs). Cynomolgus macaque. https:\/\/macaques.nc3rs.org.uk\/about-macaques\/cynomolgus-macaque. Accessed on 5 January"},{"key":"10030_CR10","unstructured":"Fidler M (2025) nlmixr2: Nonlinear Mixed Effects Models in Population PK\/PD. https:\/\/doi.org\/10.32614\/CRAN.package.nlmixr2. https:\/\/CRAN.R-project.org\/package=nlmixr2 Accessed on 24 June 2025"},{"issue":"2","key":"10030_CR11","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1208\/s12248-011-9255-z","volume":"13","author":"M Bergstrand","year":"2011","unstructured":"Bergstrand M, Hooker AC, Wallin JE, Karlsson MO (2011) Prediction-corrected visual predictive checks for diagnosing nonlinear mixed-effects models. AAPS J 13(2):143\u2013151","journal-title":"AAPS J"},{"issue":"3","key":"10030_CR12","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.vascn.2011.03.002","volume":"63","author":"KJ Watson","year":"2011","unstructured":"Watson KJ, Gorczyca WP, Umland J, Zhang Y, Chen X, Sun SZ, Fermini B, Holbrook M, Van Der Graaf PH (2011) Pharmacokinetic-pharmacodynamic modelling of the effect of Moxifloxacin on QTc prolongation in telemetered cynomolgus monkeys. J Pharmacol Toxicol Methods 63(3):304\u2013313","journal-title":"J Pharmacol Toxicol Methods"},{"issue":"3","key":"10030_CR13","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.vascn.2006.09.002","volume":"55","author":"HH Holzgrefe","year":"2007","unstructured":"Holzgrefe HH, Cavero I, Buchanan LV, Gill MW, Durham SK (2007) Application of a probabilistic method for the determination of drug-induced QT prolongation in telemetered cynomolgus monkeys: effects of moxifloxacin. J Pharmacol Toxicol Methods 55(3):227\u2013237","journal-title":"J Pharmacol Toxicol Methods"},{"key":"10030_CR14","doi-asserted-by":"crossref","unstructured":"Siefert HM, Domdey-Bette A, Henninger K, Hucke F, Kohlsdorfer C, Stass HH (1999) Pharmacokinetics of the 8-methoxyquinolone, moxifloxacin: a comparison in humans and other mammalian species. J Antimicrob Chemother 43 Suppl B :69\u201376","DOI":"10.1093\/jac\/43.suppl_2.69"},{"key":"10030_CR15","doi-asserted-by":"publisher","first-page":"106606","DOI":"10.1016\/j.vascn.2019.106606","volume":"99","author":"R Komatsu","year":"2019","unstructured":"Komatsu R, Mizuno H, Ishizaka T, Ito A, Jikuzono T, Kakoi T et al (2019) Exposure-response analysis of drug-induced QT interval prolongation in telemetered monkeys for translational prediction to human. J Pharmacol Toxicol Methods 99:106606","journal-title":"J Pharmacol Toxicol Methods"},{"key":"10030_CR16","doi-asserted-by":"publisher","first-page":"107515","DOI":"10.1016\/j.vascn.2024.107515","volume":"128","author":"TA Wisialowski","year":"2024","unstructured":"Wisialowski TA, Ether N, Foley CM, Kleiman R, Koshman Y, Leishman D et al (2024) Improving the in vivo QTc assay: Nonclinical concentration-QTc modeling for risk assessment. J Pharmacol Toxicol Methods 128:107515","journal-title":"J Pharmacol Toxicol Methods"},{"issue":"1","key":"10030_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.vascn.2009.08.001","volume":"61","author":"SD Pettit","year":"2010","unstructured":"Pettit SD, Berridge B, Sarazan RD (2010) A call for more integrated cardiovascular safety assessment. J Pharmacol Toxicol Methods 61(1):1\u20132","journal-title":"J Pharmacol Toxicol Methods"}],"container-title":["Journal of Pharmacokinetics and Pharmacodynamics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10928-026-10030-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10928-026-10030-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10928-026-10030-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T10:41:35Z","timestamp":1781952095000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10928-026-10030-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,1]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["10030"],"URL":"https:\/\/doi.org\/10.1007\/s10928-026-10030-1","relation":{},"ISSN":["1567-567X","1573-8744"],"issn-type":[{"value":"1567-567X","type":"print"},{"value":"1573-8744","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,1]]},"assertion":[{"value":"16 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20"}}